Anemia. Iron deficiency anemia
Conditions
Interventions
Intervention 1: Intervention group: This group is treated with one tablet of 80 mg ferrous glycine every other day for 12 weeks. Intervention 2: Control group: This group is treated with one tablet of
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Women with ferritin level below 35 ng/dl Women with hemoglobin below 12 g/dl within childbearing years Menopausal women with hemoglobin below 13 g/dl
Exclusion criteria
Exclusion criteria: Malignancy Abnormal uterine bleeding Systemic diseases such as uncontrolled hypothyroidism and collagen vascular diseases Unreasonable organomegaly Absorption deficiencies and unimproved anemias with oral iron treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum hemoglobin. Timepoint: At the starting point of trial , 4 and 12 weeks after treatment. Method of measurement: Complete blood count test.;Serum ferritin. Timepoint: At the starting point of trial , 4 and 12 weeks after treatment. Method of measurement: Ferritin blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal side effects such as nausea , constipation and abdominal pain. Timepoint: 4 and 12 weeks after treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Amir Sheikholeslami
Shahid Beheshti University of Medical Sciences
Outcome results
None listed